Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
4(24%)
Results Posted
57%(4 trials)
Terminated
2(12%)

Phase Distribution

Ph phase_2
1
6%
Ph not_applicable
1
6%
Ph phase_4
1
6%
Ph phase_3
3
18%
Ph early_phase_1
5
29%
Ph phase_1
6
35%

Phase Distribution

11

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution17 total trials
Early Phase 1First-in-human
5(29.4%)
Phase 1Safety & dosage
6(35.3%)
Phase 2Efficacy & side effects
1(5.9%)
Phase 3Large-scale testing
3(17.6%)
Phase 4Post-market surveillance
1(5.9%)
N/ANon-phased studies
1(5.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

4

trials recruiting

Total Trials

17

all time

Status Distribution
Active(7)
Completed(7)
Terminated(3)

Detailed Status

Completed7
Recruiting4
Not yet recruiting3
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
4
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 15 (29.4%)
Phase 16 (35.3%)
Phase 21 (5.9%)
Phase 33 (17.6%)
Phase 41 (5.9%)
N/A1 (5.9%)

Trials by Status

withdrawn16%
recruiting424%
terminated212%
completed741%
not_yet_recruiting318%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT07664176Phase 1

NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors

Not Yet Recruiting
NCT07145801Phase 2

Y-90 Treatment Response Using Transarterial Radioembolization

Recruiting
NCT07274787Not Applicable

Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma

Not Yet Recruiting
NCT06600880Phase 1

Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau

Not Yet Recruiting
NCT03107520Early Phase 1

Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH

Recruiting
NCT06329570Phase 1

Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

Recruiting
NCT06400004Phase 3

Lumason® Infusion vs. Bolus Administrations

Recruiting
NCT05957042Early Phase 1

Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).

Withdrawn
NCT04718441Phase 1

Contrast Ultrasound for Pediatric Trauma - Comparative Evaluation (CAPTURE Study)

Completed
NCT05613946Phase 1

Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema

Completed
NCT04569799Phase 4

Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post TACE

Completed
NCT04150874Early Phase 1

Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE

Terminated
NCT03954015Early Phase 1

Comparison of Three Methods for Early Detection of Breast Cancer

Completed
NCT02552238Phase 3

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

Completed
NCT02522481Phase 3

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141

Completed
NCT03147690Phase 1

Contrast-Enhanced Ultrasound in the Evaluation of Abdominal Injuries in Children

Terminated
NCT03296852Early Phase 1

Study: SONAS Ultrasound for Detecting Stroke SONAS Ultrasound for Detecting Stroke

Completed

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17